Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Streptococcus agalactiae | 7 | 2008 | 336 | 1.240 |
Why?
|
Glycosaminoglycans | 3 | 2008 | 606 | 0.670 |
Why?
|
Antigens, Surface | 4 | 2007 | 1607 | 0.580 |
Why?
|
Bacterial Proteins | 5 | 2007 | 3824 | 0.410 |
Why?
|
Bacterial Translocation | 1 | 2007 | 73 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2007 | 191 | 0.280 |
Why?
|
Cervix Uteri | 3 | 2007 | 585 | 0.260 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2005 | 90 | 0.250 |
Why?
|
Bacteriological Techniques | 1 | 2006 | 279 | 0.240 |
Why?
|
Lymphoma, T-Cell | 1 | 2007 | 306 | 0.240 |
Why?
|
Immunoglobulins, Intravenous | 3 | 1996 | 662 | 0.220 |
Why?
|
Meningitis, Bacterial | 1 | 2005 | 221 | 0.220 |
Why?
|
Virulence Factors | 1 | 2007 | 508 | 0.220 |
Why?
|
Streptococcal Infections | 2 | 2007 | 616 | 0.200 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1125 | 0.200 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 935 | 0.180 |
Why?
|
Drosophila melanogaster | 1 | 2008 | 1709 | 0.170 |
Why?
|
Epithelial Cells | 4 | 2007 | 3664 | 0.150 |
Why?
|
Hepatitis C | 3 | 1996 | 1580 | 0.150 |
Why?
|
Actins | 1 | 2004 | 2049 | 0.140 |
Why?
|
Drug Contamination | 2 | 1996 | 151 | 0.130 |
Why?
|
Hepacivirus | 3 | 1996 | 1333 | 0.120 |
Why?
|
Bacterial Adhesion | 2 | 2007 | 306 | 0.120 |
Why?
|
Protein Binding | 4 | 2007 | 9334 | 0.110 |
Why?
|
Sepsis | 1 | 2006 | 2593 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 8489 | 0.090 |
Why?
|
Protein Structure, Tertiary | 3 | 2007 | 3800 | 0.090 |
Why?
|
Cell Line | 3 | 2008 | 15638 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2007 | 1695 | 0.080 |
Why?
|
Mycobacterium Infections | 1 | 2008 | 121 | 0.070 |
Why?
|
Lipectomy | 1 | 2008 | 110 | 0.070 |
Why?
|
Abdominal Fat | 1 | 2008 | 223 | 0.070 |
Why?
|
Genital Diseases, Female | 1 | 2007 | 191 | 0.060 |
Why?
|
Crystallography, X-Ray | 2 | 2007 | 1978 | 0.060 |
Why?
|
Glycolipids | 1 | 2005 | 204 | 0.060 |
Why?
|
Chlorates | 1 | 2004 | 12 | 0.060 |
Why?
|
Digitonin | 1 | 2004 | 26 | 0.060 |
Why?
|
Polysaccharide-Lyases | 1 | 2004 | 47 | 0.060 |
Why?
|
Cytochalasin D | 1 | 2004 | 91 | 0.060 |
Why?
|
Cytotoxins | 1 | 2004 | 153 | 0.050 |
Why?
|
History, 19th Century | 1 | 2006 | 720 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2004 | 530 | 0.050 |
Why?
|
Flow Cytometry | 2 | 2004 | 5841 | 0.050 |
Why?
|
Immunologic Deficiency Syndromes | 2 | 1996 | 556 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1737 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2008 | 1787 | 0.050 |
Why?
|
Point Mutation | 1 | 2007 | 1594 | 0.050 |
Why?
|
Cytosol | 1 | 2004 | 887 | 0.050 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2000 | 24 | 0.050 |
Why?
|
Immunoassay | 1 | 2004 | 748 | 0.040 |
Why?
|
RNA Interference | 1 | 2008 | 2848 | 0.040 |
Why?
|
Cytoplasm | 1 | 2004 | 1521 | 0.040 |
Why?
|
Cell Polarity | 1 | 2002 | 638 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2007 | 16878 | 0.040 |
Why?
|
Aspergillosis | 1 | 2000 | 243 | 0.040 |
Why?
|
Gastrointestinal Diseases | 1 | 2007 | 1190 | 0.040 |
Why?
|
Bacterial Toxins | 1 | 2004 | 931 | 0.040 |
Why?
|
Protein Transport | 1 | 2004 | 1967 | 0.040 |
Why?
|
Biological Transport | 1 | 2002 | 2086 | 0.040 |
Why?
|
Binding Sites | 1 | 2007 | 6054 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2004 | 1975 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2007 | 13439 | 0.040 |
Why?
|
Animals | 6 | 2008 | 167531 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 3443 | 0.040 |
Why?
|
History, 20th Century | 1 | 2006 | 2775 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1999 | 345 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2007 | 17611 | 0.030 |
Why?
|
Heparin | 1 | 2004 | 1656 | 0.030 |
Why?
|
Kinetics | 1 | 2004 | 6373 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 2002 | 1155 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 2002 | 1469 | 0.030 |
Why?
|
Polymerase Chain Reaction | 3 | 2008 | 6070 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5790 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 1999 | 824 | 0.030 |
Why?
|
Common Variable Immunodeficiency | 1 | 1996 | 102 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1914 | 0.030 |
Why?
|
Cell Membrane | 1 | 2004 | 3682 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 1996 | 607 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 1996 | 1702 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7593 | 0.030 |
Why?
|
Female | 10 | 2008 | 390174 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2005 | 5100 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 10825 | 0.020 |
Why?
|
Humans | 13 | 2008 | 759098 | 0.020 |
Why?
|
Mice | 3 | 2007 | 80993 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2002 | 4526 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18094 | 0.020 |
Why?
|
Dominican Republic | 1 | 2008 | 74 | 0.020 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2008 | 144 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2005 | 26099 | 0.020 |
Why?
|
Mycobacterium | 1 | 2008 | 250 | 0.020 |
Why?
|
Risk | 1 | 1996 | 9622 | 0.010 |
Why?
|
Mutation | 1 | 2008 | 29878 | 0.010 |
Why?
|
Crystallization | 1 | 2005 | 534 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 1996 | 12152 | 0.010 |
Why?
|
Boston | 1 | 1996 | 9274 | 0.010 |
Why?
|
Time Factors | 1 | 2004 | 40083 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2002 | 3793 | 0.010 |
Why?
|
Travel | 1 | 2008 | 787 | 0.010 |
Why?
|
Logistic Models | 1 | 1996 | 13309 | 0.010 |
Why?
|
Pregnancy | 1 | 2002 | 29650 | 0.010 |
Why?
|
Child | 3 | 1996 | 79604 | 0.010 |
Why?
|
Cytochrome c Group | 1 | 1999 | 121 | 0.010 |
Why?
|
Moths | 1 | 1999 | 81 | 0.010 |
Why?
|
Disease Outbreaks | 1 | 2008 | 1757 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2002 | 975 | 0.010 |
Why?
|
Male | 4 | 2008 | 358602 | 0.010 |
Why?
|
Hepatitis, Chronic | 1 | 1996 | 52 | 0.010 |
Why?
|
CHO Cells | 1 | 1999 | 1388 | 0.010 |
Why?
|
Hepatitis C Antibodies | 1 | 1996 | 145 | 0.010 |
Why?
|
Glycosylation | 1 | 1999 | 1092 | 0.010 |
Why?
|
Phagocytosis | 1 | 2002 | 1535 | 0.010 |
Why?
|
Clone Cells | 1 | 1999 | 1657 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1999 | 796 | 0.010 |
Why?
|
Cricetinae | 1 | 1999 | 2424 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1999 | 1412 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2000 | 857 | 0.010 |
Why?
|
Cohort Studies | 1 | 1996 | 41266 | 0.010 |
Why?
|
HIV Infections | 1 | 2000 | 17126 | 0.010 |
Why?
|
Antigen Presentation | 1 | 1999 | 1247 | 0.010 |
Why?
|
Viremia | 1 | 1996 | 708 | 0.010 |
Why?
|
Middle Aged | 4 | 2008 | 219628 | 0.010 |
Why?
|
Adult | 4 | 2008 | 219353 | 0.010 |
Why?
|
Ligands | 1 | 1999 | 3272 | 0.010 |
Why?
|
Transfection | 1 | 1999 | 5781 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 1999 | 1972 | 0.010 |
Why?
|
Adolescent | 2 | 1996 | 87551 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 18937 | 0.010 |
Why?
|
RNA, Viral | 1 | 1996 | 2837 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1996 | 80125 | 0.000 |
Why?
|
Peptides | 1 | 1999 | 4325 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2008 | 15662 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 2000 | 12963 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1999 | 10069 | 0.000 |
Why?
|
United States | 1 | 2008 | 72238 | 0.000 |
Why?
|
Prognosis | 1 | 2000 | 29559 | 0.000 |
Why?
|
Child, Preschool | 1 | 1996 | 41932 | 0.000 |
Why?
|
Prospective Studies | 1 | 1996 | 54190 | 0.000 |
Why?
|
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_